Opendata, web and dolomites

Nano-OligoMed SIGNED

Hybrid Nanostructured Oligonucleotide Platforms for Biomedical Applications

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Nano-OligoMed project word cloud

Explore the words cloud of the Nano-OligoMed project. It provides you a very rough idea of what is the project "Nano-OligoMed" about.

degradation    function    countries    degradable    inert    broadening    experts    molecular    generate    last    networking    programmable    input    biomedicine    bio    payload    nano    medicine    exchange    oligonucleotides    combination    sciences    multidisciplinary    young    chemical    international    scientific    safe    technological    decades    electronics    nanomaterials    combine    skills    cancer    efficient    cell    drug    interaction    artificial    therapeutic    ambition    drugs    mirnas    competences    internalization    breakthroughs    agents    phd    activation    material    oligonucleotide    educational    transfer    academic    structures    mobility    students    enabled    nanotechnology    creation    scientists    team    received    possibility    training    oligomed    diversity    hybrid    rigid    systemic    arise    biology    mimics    collaborative    dna    silica    network    extra    sectors    delicate    senior    responsive    materials    strategies    intrinsic    joint    carrier   

Project "Nano-OligoMed" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITE DE STRASBOURG 

Organization address
address: RUE BLAISE PASCAL 4
city: STRASBOURG
postcode: 67081
website: http://www.unistra.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 598˙500 €
 EC max contribution 598˙500 € (100%)
 Programme 1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
 Code Call H2020-MSCA-RISE-2017
 Funding Scheme MSCA-RISE
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2021-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITE DE STRASBOURG FR (STRASBOURG) coordinator 180˙000.00
2    UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA IT (ROMA) participant 162˙000.00
3    UNIVERSITA DEGLI STUDI DI PARMA IT (PARMA) participant 130˙500.00
4    NANOMOL TECHNOLOGIES SL ES (CERDANYOLA DEL VALLES) participant 126˙000.00
5    ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING MCGILL UNIVERSITY CA (MONTREAL) partner 0.00
6    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA US (OAKLAND CA) partner 0.00
7    UNIVERSIDAD DE LA HABANA CU (PLAZA) partner 0.00

Map

 Project objective

Nanotechnology has received widespread attention in the last several decades due to the technological breakthroughs it has enabled across sectors from electronics to medicine. Towards the great challenges that nanotechnology arise, Nano-OligoMed has the ambition to establish and support a network of international collaboration, enabling a collaborative scientific team to effectively use a diversity of approaches and strategies to generate and test hybrid nanomaterials for the efficient and safe systemic delivery of oligonucleotide-based therapeutic agents. To this end, we have set-up a joint multidisciplinary scientific collaborative programme that through exchange, international mobility, and strongly collaborative transfer of knowledge and training activities between 4 European and 3 extra-European countries, will bring together leading experts under the field of “nanomaterials in biomedicine”. The scientific aim of Nano-OligoMed is the creation of degradable hybrid structures that combine the rigid, inert silica with the delicate programmable oligonucleotides or artificial oligonucleotide-mimics. The possibility to develop novel oligonucleotide-based materials will enable a) the degradation of the drug carrier at the presence of a specific input as a function of the intrinsic bio-responsive feature of oligonucleotides, b) the activation of a therapeutic function as a result of the bio-molecular interaction between the oligonucleotide-based material and the molecular target (i.e. miRNAs) and c) the delivery of the chemical payload (DNA and/or artificial mimics, even in combination with cancer drugs) upon cell internalization. The international academic networking, the broadening of the research skills, the educational activities, will provide to young (PhD students) and senior scientists, specific competences in the field of materials sciences, nanotechnology, molecular biology and molecular medicine.

 Deliverables

List of deliverables.
Protocols for the characterization of the behavior of hybrid supramolecular nanostructures Other 2020-02-12 16:29:25
DNA/PNA-BioMSNPs Other 2020-02-07 12:43:53
School on synthesis and characterization of hybrid materials for medical applications Other 2020-02-07 12:44:16
Protocol for the study of stimuli-responsive DNA nanomachines Other 2019-10-10 12:56:42
Porous silicon nanoparticles Other 2019-10-10 12:56:28
Protocol for the synthesis of DNA, its modification and conjugation with FRET pair and small molecules Other 2019-10-10 12:56:30
Project website Websites, patent fillings, videos etc. 2019-10-10 12:56:29

Take a look to the deliverables list in detail:  detailed list of Nano-OligoMed deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NANO-OLIGOMED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NANO-OLIGOMED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

EXPLOR (2020)

EXperimentation and simulation based PLatform for beyond 5G Optical-wireless network Research and development

Read More  

SOMPATY (2020)

Spectral Optimization: From Mathematics to Physics and Advanced Technology

Read More  

EM4FIT (2020)

Entrepreneurial Management for Fostering Innovation and Talents

Read More